Interaction among fibronectin, Src, and TGF-β1/Smad related to RCC cellular activities and intracellular signaling was further demonstrated by the results of experiments involving Src inhibitor- and TGF-β1-treated cells. This evidence concerns the gene TGFB1 and renal cell carcinoma.